Brief: Inovio Pharmaceuticals Q2 Operating Expenses USD 18.6 Million
12/08/2026 21:06
BRIEF-Inovio Pharmaceuticals Q2 Operating Expenses USD 18.6 Million Aug 12 (Reuters) - Inovio Pharmaceuticals Q2 net income USD -6 million.
- Q2 EPS USD -0.07
Recent news on Inovio Pharmaceuticals
See all newsBrief: Inovio Announces Favorable Judgment In Litigation With Vgxi, Inc. And Geneone Life Science
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
Inovio Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Inovio Q2 net loss narrows on warrant gain, lower costs
Brief: Inovio Pharmaceuticals Q2 Operating Expenses USD 18.6 Million